Mexiletine for the Treatment of Muscle Cramps in ALS
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucd Telehealth Network - Lake Almanor Clinic
Chester, California, United States
- Ucsd Department of Neurosciences Als Clinical Trials (act) Program
La Jolla, California, United States
- Ucla Neuromuscular Research Program
Los Angeles, California, United States
- Ucd Telehealth Network
Multiple Locations, California, United States
- Uc Irvine Health Als & Neuromuscular Center
Orange, California, United States
- Uc, Davis Medical Center Als Clinic
Sacramento, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2013
- Primary completion
- 31 Mar 2016
- Completion
- 31 May 2016
- Last update posted
- 28 Aug 2017
- Registered enrollment
- 23
- Registry id
- NCT01811355
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.